Nutrition Research
Volume 26, Issue 4 , Pages 180-185 , April 2006

Synergy between 677 TT MTHFR genotype and related folate SNPs regulates homocysteine level

Received 5 February 2005 ,Revised 2 December 2005 ,Accepted 3 January 2006.

References 

  1. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig M. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999;6:359–365
  2. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057
  3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  4. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96:12810–12815
  5. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomark Prev. 1999;8:513–518
  6. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. The effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst. 2004;96:134–144
  7. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res. 1997;57:1098–1102
  8. Lucock MD, Yates Z. A differential role for folate in developmental disorders, vascular disease and other clinical conditions: the importance of folate status and genotype. In:  Massaro EJ editors. Chapter in folate and human development. Totowa (NJ): Humana Press; 2001;p. 263–298
  9. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome. Am J Clin Nutr. 1999;70:495–501
  10. Mills JL, Kirke PN, Molloy AM, Burke H, Conley MR, Lee J, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral cleft. Am J Med Genet. 1999;86:71–74
  11. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van der Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070
  12. Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol. 2000;27:157–167
  13. Lucock M, Yates Z, Glanville T, Leeming R, Simpson R, Daskalakis I. A critical role for B-vitamin nutrition in human developmental and evolutionary biology. Nutr Res. 2003;23:1463–1475
  14. Muller M, Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet. 2003;4:315–322
  15. Lucock M, Daskalakis I, Hinkins M, Yates Z. An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol Genet Metab. 2001;73:322–332
  16. Van der Put NMJ, Van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JMF, Eskes TKAB, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in NTD and vascular disease. Q J Med. 1997;90:511–517
  17. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67:317–323
  18. Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects?. Am J Hum Genet. 1998;62:1044–1051
  19. Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M. Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003;63:2280–2285
  20. Daskalakis I, Lucock MD, Anderson A, Wild J, Schorah CJ, Levene MI. Determination of plasma total homocysteine and cysteine using HPLC with fluorescence detection and an ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulphonate (SBDF-) derivitization protocol optimised for antioxidant concentration, derivitization reagent concentration, temperature and matrix pH. Biomed Chromatogr. 1996;10:205–212
  21. Lucock MD, Wild J, Smithells R, Hartley R. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: a model for future studies. Biochem Med Metab Biol. 1989;42:30–42
  22. Lucock M. Clinical review science, medicine, and the future: is folic acid the ultimate functional food component for disease prevention?. BMJ. 2004;328:211–214
  23. Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry. 2000;39:13005–13011

PII: S0271-5317(06)00017-0

doi: 10.1016/j.nutres.2006.01.001

Nutrition Research
Volume 26, Issue 4 , Pages 180-185 , April 2006

Article Tools

* Image Usage & Resolution